| Item Type | Name |
|
Concept
|
Anti-Inflammatory Agents, Non-Steroidal
|
|
Concept
|
Nonprescription Drugs
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Fatty Acids, Nonesterified
|
|
Concept
|
Nonmuscle Myosin Type IIA
|
|
Concept
|
Cognitive Dysfunction
|
|
Concept
|
Statistics, Nonparametric
|
|
Concept
|
Lymphoma, Non-Hodgkin
|
|
Academic Article
|
Cognitive impairment in geriatric chronic schizophrenic patients: a cross-national study in New York and London.
|
|
Academic Article
|
Fiber intake and risk of developing non-insulin-dependent diabetes mellitus.
|
|
Academic Article
|
Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent.
|
|
Academic Article
|
Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.
|
|
Academic Article
|
Efficacy of over-the-counter nutritional supplements.
|
|
Academic Article
|
Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men.
|
|
Academic Article
|
Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
|
|
Academic Article
|
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
|
|
Academic Article
|
Non-high-density lipoprotein cholesterol: the forgotten therapeutic target.
|
|
Academic Article
|
Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.
|
|
Academic Article
|
Relationship of traditional and nontraditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes.
|
|
Academic Article
|
Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
|
|
Academic Article
|
Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein.
|
|
Academic Article
|
Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls.
|
|
Academic Article
|
Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation.
|
|
Academic Article
|
Over-the-counter nicotine patch therapy for smoking cessation: results from randomized, double-blind, placebo-controlled, and open label trials.
|
|
Academic Article
|
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.
|
|
Academic Article
|
Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure?
|
|
Academic Article
|
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
|
|
Academic Article
|
Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
|
|
Academic Article
|
A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
|
|
Academic Article
|
Convergence of cognitive and adaptive decline in late-life schizophrenia.
|
|
Academic Article
|
Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment.
|
|
Academic Article
|
Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients.
|
|
Academic Article
|
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study.
|
|
Academic Article
|
Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders.
|
|
Academic Article
|
Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment.
|
|
Academic Article
|
Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials.
|
|
Academic Article
|
The cost of cognitive impairment in schizophrenia.
|
|
Academic Article
|
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
|
|
Academic Article
|
Brief neuroleptic discontinuation and clinical symptoms in Kraepelinian and non-Kraepelinian chronic schizophrenic patients.
|
|
Academic Article
|
Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder.
|
|
Academic Article
|
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
|
|
Academic Article
|
Validation of the modified telephone interview for cognitive status (TICS-m) in Hebrew.
|
|
Academic Article
|
Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study.
|
|
Academic Article
|
A STUDY OF BLOOD GLUCOSE AND KETONE BODIES AND PLASMA FREE FATTY ACIDS, CHOLESTEROL, PHOSPHOLIPIDS AND TOTAL LIPIDS IN JUVENILE DIABETES.
|
|
Academic Article
|
The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach.
|
|
Academic Article
|
The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients.
|
|
Academic Article
|
The association between adaptive and cognitive deficits in geriatric chronic schizophrenic patients.
|
|
Academic Article
|
Symptom severity and cognitive impairment in chronically hospitalised geriatric patients with affective disorders.
|
|
Academic Article
|
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
|
|
Academic Article
|
The response of blood glucose, ketones, and plasma nonesterified fatty acids to fasting and epinephrine injection in infants and children.
|
|
Academic Article
|
Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients.
|
|
Academic Article
|
Verbal fluency deficits in geriatric and nongeriatric chronic schizophrenic patients.
|
|
Academic Article
|
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).
|
|
Academic Article
|
Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
|
|
Academic Article
|
Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites.
|
|
Academic Article
|
Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL.
|
|
Academic Article
|
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.
|
|
Academic Article
|
A contractile and counterbalancing adhesion system controls the 3D shape of crawling cells.
|
|
Academic Article
|
Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
|
|
Academic Article
|
Perspectives: Benefits of a new, nonsystemic lipid-lowering agent: the clinician's perspective.
|
|
Academic Article
|
Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms: Results From a Randomized Controlled Trial.
|
|
Academic Article
|
Cardiorenal Safety of OTC Analgesics.
|
|
Academic Article
|
Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia.
|
|
Academic Article
|
Cognitive impairment and psychosis in schizophrenia: independent or linked conditions?
|
|
Academic Article
|
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
|
|
Academic Article
|
A phase II trial of prednisone, oral etoposide, and novantrone (PEN) as initial treatment of non-Hodgkin's lymphoma in elderly patients.
|